GBA Presents: House of Gummy-!

Discussion in 'Stocks' started by stonedinvestor, May 13, 2023.

  1. In looking for year 24' ideas one group will be the comeback kids stocks that have not done well. And in Bumble we have just that.

    Another sub sector will be plays pinging off the weight loss drugs/ society.
    And Bumble scores there as well. Thin people like to get laid.

    It's expensive & I do not know how the Co makes money.
    If anyone has used Bumble.. chip in on the experience.

    Is This a swipe right sik?> Is that this stk? The swiping?


    YEAR 24' IDEA->BMBL Bumble Inc.

    $14.34-0.02(-0.14%)1:39 PM 12/13/23
     
    #10631     Dec 13, 2023
  2. I’ve been playing the strange flow on CCCC, I made a few coins off the $2.50 calls and $5c. Holding some for $6.
     
    #10632     Dec 13, 2023
  3. VAN - do we officially close House Of Gummy for the fourth time at the new year and then start a YEAR 24 thread?

    might be a good idea. Otherwise House Of Gummy will continue on and on and on...

    Incyte Stock Is the S&P 500’s Top Performer. Here’s Why It’s Surging.

    Dec 12, 2023, 12:43 pm EST


    INCY

    best trading session in more than six years.


    The stock rose 8.6% to $61.97 on Tuesday, putting Incyte shares on pace for their largest increase since Aug. 30, 2017, when they gained 11%, according to Dow Jones Market Data. It was the top performer in the S&P 500

    The two days of gains likely stem from data announced at the American Society of Hematology annual meeting that began Dec. 9 and runs through Tuesday.

    In a press release Sunday, Incyte and Syndax Pharmaceuticals
    shared full results of a phase 2 trial of antibody axatilimab in adult and pediatric patients with refractory chronic graft-versus-host disease (GVHD) who had received at least two prior lines of systemic therapy. GVHD is defined by the National Library of Medicine as a systemic disease that occurs when transplanted tissue’s immune cells view the person’s own tissues as foreign and attack those cells.



    The two companies said the trial met the primary endpoint across all cohorts receiving the antibody. Based on the results and a pending agreement from the Food and Drug Administration, they expect to submit a biologics license application to the FDA by the end of the year.
     
    #10633     Dec 13, 2023
  4. RILY a BK or dilution from Hell? Price is toxic.
     
    #10634     Dec 13, 2023


  5. BLBD Ted! Options flying. Jan 19 $25's -> +38% // Jan $30's + 50% <-- Only .30 cents :wtf:

    Dec 15 $22.50's + 142%

    Weeeeeeeeeeeeeeeeeeeeeeeeee :cool:

    vol up

    BLBD-------------VOL Alert***********1,016,611

    Avg. Volume-->316,758
     
    #10635     Dec 13, 2023
  6. DAY 18 OF THE CRAMER CORRECTION IS EVERYONE ALRIGHT-?

    S&P 500 (^GSPC)
    SNP - SNP Real Time Price.
    4,672.81+29.11(+0.63%)
    As of 02:05PM EST.
     
    #10636     Dec 13, 2023
  7. Van you shouldn't have
     
    #10637     Dec 13, 2023
  8. Watch Dem' Words-
     
    #10638     Dec 13, 2023
  9. What happens and this will happen when the first human accuses a robot of inappropriate touching?

     
    #10639     Dec 13, 2023
  10. God this is so sad

     
    #10640     Dec 13, 2023